NeOnc Technologies to Highlight Advances in Brain Cancer Research on Nationwide TV Broadcast’
On September 25, 2025, NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI a clinical-stage biotechnology company specializing in therapies for central nervous system (CNS) cancers, will be featured on the health-oriented television program “Health Uncensored,” hosted by Dr. Drew Pinsky. This event is poised to capture the attention of approximately 63 million television households across the United States as it airs on the Lifetime Network at 8:00 a.m. ET/PT.
The episode aims to showcase NeOnc’s innovative approaches and recent progress in the fight against brain cancer, a malignancy that poses significant challenges both for patients and medical professionals. Given brain cancer’s notoriously complex nature and the limited effectiveness of existing treatments, highlighting advances in this field is particularly relevant. The broadcast represents a strategic opportunity for NeOnc Technologies to engage with a broader audience, raising awareness about its research initiatives and potential therapies that may contribute to improved patient outcomes.
The show has a strong viewership base, averaging over 500,000 viewers per episode, which underscores the potential for substantial exposure. Such visibility is critical for biotechnology firms in garnering public interest and investment support for ongoing clinical trials.
As NeOnc Technologies nears the airing of this episode, stakeholders await the insights it promises to offer regarding its pioneering work. The convergence of media and biotechnology in this context exemplifies a growing trend of utilizing mainstream platforms to communicate significant health advancements to the public, potentially fostering greater understanding and investment in the field of cancer research.
Comments